(Q45292868)

English

Objective assessment of motor slowness in Huntington's disease: clinical correlates and 2-year follow-up

scientific article published in March 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Objective assessment of motor slowness in Huntington's disease: clinical correlates and 2-year follow-up (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Huntington's disease

0 references

Raymund A. C. Roos

7

object named as

Raymund A C Roos

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Aeilko H Zwinderman

5

object named as

Aeilko H Zwinderman

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

author name string

Jeroen P P van Vugt

1

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Karlijne K E Piet

2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Liesbeth J Vink

3

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Sabine Siesling

4

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Huub A M Middelkoop

6

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

language of work or name

0 references

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Movement Disorders

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

285-297

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Bradykinesia in early Huntington's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10718

21 January 2018

Motor changes in presymptomatic Huntington disease gene carriers

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10718

21 January 2018

Huntington's disease in Venezuela: neurologic features and functional decline

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10718

21 January 2018

Early cognitive and motor symptoms in identified carriers of the gene for Huntington disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10718

21 January 2018

Rate of functional decline in Huntington's disease. Huntington Study Group

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10718

21 January 2018

Retest effects and cognitive decline in longitudinal follow-up of patients with early HD.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10718

21 January 2018

Objective assessment of progression in Huntington's disease: a 3-year follow-up study.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10718

21 January 2018

Huntington disease: functional capacities in patients treated with neuroleptic and antidepressant drugs

1 reference

https://api.crossref.org/works/10.1002%2FMDS.10718

21 January 2018

Identifiers

10.1002/MDS.10718

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45292868&oldid=2128815436"